Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 327

1.

Regulation of TCR-mediated T cell activation by TNF-RII.

Aspalter RM, Eibl MM, Wolf HM.

J Leukoc Biol. 2003 Oct;74(4):572-82. Epub 2003 Jul 1.

PMID:
12960285
3.

Chronic TNF-alpha exposure impairs TCR-signaling via TNF-RII but not TNF-RI.

Aspalter RM, Wolf HM, Eibl MM.

Cell Immunol. 2005 Sep;237(1):55-67. Epub 2005 Dec 1.

PMID:
16325164
5.

Defective T-cell activation caused by impairment of the TNF receptor 2 costimulatory pathway in common variable immunodeficiency.

Aspalter RM, Eibl MM, Wolf HM.

J Allergy Clin Immunol. 2007 Nov;120(5):1193-200. Epub 2007 Sep 7.

PMID:
17825894
6.

TNF type 2 receptor (p75) lowers the threshold of T cell activation.

Kim EY, Teh HS.

J Immunol. 2001 Dec 15;167(12):6812-20.

7.

Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.

Gilfillan MC, Noel PJ, Podack ER, Reiner SL, Thompson CB.

J Immunol. 1998 Mar 1;160(5):2180-7.

9.

CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.

Sepulveda H, Cerwenka A, Morgan T, Dutton RW.

J Immunol. 1999 Aug 1;163(3):1133-42.

12.

TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx.

Church LD, Hessler G, Goodall JE, Rider DA, Workman CJ, Vignali DA, Bacon PA, Gulbins E, Young SP.

J Leukoc Biol. 2005 Jul;78(1):266-78. Epub 2005 Apr 7.

PMID:
15817701
13.

CD28 molecule as a receptor-like function for accessory signals in cell-mediated augmentation of IL-2 production.

Kohno K, Shibata Y, Matsuo Y, Minowada J.

Cell Immunol. 1990 Nov;131(1):1-10.

PMID:
2171783
14.

T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways.

Van Lier RA, Brouwer M, De Groot ED, Kramer I, Aarden LA, Verhoeven AJ.

Eur J Immunol. 1991 Jul;21(7):1775-8.

PMID:
1647959
15.
16.

TNFRI is a positive T-cell costimulatory molecule important for the timing of cytokine responses.

Evangelidou M, Tseveleki V, Vamvakas SS, Probert L.

Immunol Cell Biol. 2010 Jul;88(5):586-95. doi: 10.1038/icb.2010.12. Epub 2010 Mar 9.

PMID:
20212506
17.

Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody.

Holsti MA, McArthur J, Allison JP, Raulet DH.

J Immunol. 1994 Feb 15;152(4):1618-28.

PMID:
7907103
19.

Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.

Hombach A, Wieczarkowiecz A, Marquardt T, Heuser C, Usai L, Pohl C, Seliger B, Abken H.

J Immunol. 2001 Dec 1;167(11):6123-31. Erratum in: J Immunol. 2004 Jul 1;173(1):695.

Supplemental Content

Support Center